Tela Bio Inc Expected To Post A Loss Of 56 Cents A Share: Earnings Preview

TELA Bio

10/05/2023 03:03

* TELA Bio Inc  TELA.OQ   TELA.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 11. 
    * The Malvern Pennsylvania-based  company is expected to
report  a
46.0% increase in revenue to $12.019 million from $8.23 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TELA Bio Inc is for
a
loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$18​, above​ its last closing price of $9.96. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.51       -0.55      -0.52     Beat    4.8
 Sep. 30 2022  -0.63       -0.63      -0.64     Missed  -2.3
 Jun. 30 2022  -0.65       -0.62      -0.79     Missed  -27.8​
 Mar. 31 2022  -0.56       -0.56      -0.75     Missed  -34.5
 ​​Dec.                    -0.55      -0.59     Missed  -7.8
 31 2021                                                
 Sep. 30 2021  -0.54       -0.52      -0.57     Missed  -8.6​
 Jun. 30 2021  -0.53       -0.52      -0.57     Missed  -9.6
 Mar. 31 2021  -0.49       -0.48      -0.56     Missed  -16.1
 This summary was machine generated May 10 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated